<DOC>
	<DOCNO>NCT01440699</DOCNO>
	<brief_summary>Adipose-derived stem cell property differentiation various type cell , immunomodulatory effect . adipose-derived stem cell ( ASCs ) show also low immunogenicity . Anterogen develop ANTG-ASC ( Autologous ASC ) show good efficacy safety Phase I II study patient Crohn 's fistula . However , Crohn 's patient sometimes fat enough extract fat tissue culture ASCs . Therefore investigator plan study allogenic ASCs safety efficacy patient Crohn 's fistula .</brief_summary>
	<brief_title>Study Allogenic Adipose-derived Stem Cells Crohn 's Fistula</brief_title>
	<detailed_description />
	<mesh_term>Fistula</mesh_term>
	<criteria>Diagnosed Crohn 's disease Crohn 's fistula last least 3 month Negative betaHCG pregnancy test Medical history Variant Creutzfeldt Jacobs Disease Allergic anesthetic bovine protein fibrin glue autoimmune disease Crohn 's disease Infectious disease Sepsis active tuberculosis pregnant breast feed woman Inflammatory Bowel disease Crohn 's disease active crohn 's disease CDAI score &gt; 200 malignant tumor fistula 's diameter &gt; 2 cm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Crohn 's fistula</keyword>
</DOC>